Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders.
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.
Study Suggests Targeting B Cells May Help with MS
Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
The little compound that could: how phenytoin changed drug discovery and development.
Acorda Therapeutics announces positive AMPYRA® (dalfampridine) Phase 2 data in people with post-stroke deficits
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.
Physiopathology of symptoms and signs in multiple sclerosis.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial.
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
Receptos begins enrollment of Phase 3 trial of RPC1063 in relapsing multiple sclerosis
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
Medical marijuana: clearing away the smoke.
Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia.
[Diagnosis of multiple sclerosis - the 2010 revision of the McDonald criteria.]
Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
Sanofi sees US FDA ruling for MS drug Lemtrada in Q4
Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
Comprehending the inexplicable: qualitative accounts of black Caribbean and white british people severely affected by multiple sclerosis.
Drugs to be Discontinued
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
Effects of Panax ginseng in Neurodegenerative Diseases.

Pages